Satoshi Itadani
11Patents
2h-index
15Co-inventors
47Inventor score
Filing activity: Aug 31, 2004 → Apr 5, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7763610B2 | Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases | Chemistry; Metallurgy | 3 | Active |
| US8115014B2 | Ethynylindole compounds | Human Necessities | 2 | Active |
| US9993479B2 | Trk-inhibiting compound | Emerging Cross-Sectional Technologies | 1 | Active |
| US9763943B2 | Trk-inhibiting compound | Emerging Cross-Sectional Technologies | 1 | Active |
| US9463192B2 | Trk-inhibiting compound | Emerging Cross-Sectional Technologies | 1 | Active |
| US9498453B2 | Trk-inhibiting compound | Emerging Cross-Sectional Technologies | 1 | Active |
| US10765676B2 | Trk-inhibiting compound | Emerging Cross-Sectional Technologies | 0 | Active |
| US8598223B2 | Crystalline forms of 4, 4′-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid, and 4,4′-[4-fluoro-2-methyl-7-({4-[4-(2, 3, 4, 6-tetrafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid | Human Necessities | 0 | Active |
| US8318952B2 | Substituted indole derivatives for the treatment of respiratory diseases | Chemistry; Metallurgy | 0 | Active |
| US10300060B2 | Trk-inhibiting compound | Emerging Cross-Sectional Technologies | 0 | Active |
| US10399959B2 | Acid-addition salt of Trk-inhibiting compound | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.